Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCL8 | P10145 | 5/20 | 0.62 |
| ▸ | GLP1R | P43220 | 10/20 | 0.61 |
| ▸ | GCGR | P47871 | 3/20 | 0.61 |
| ▸ | GIPR | P48546 | 7/20 | 0.60 |
| ▸ | NMBR | P28336 | 1/20 | 0.59 |
| ▸ | GRPR | P30550 | 1/20 | 0.59 |
| ▸ | GALR2 | O43603 | 1/20 | 0.58 |
| ▸ | GALR1 | P47211 | 1/20 | 0.58 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Galantide SCHEMBL31332196 | 0.97 | IL23R (0.62) | CXCL8GLP1RGCGRGIPRNMBR | |
| SCHEMBL30429448 | 0.89 | GALR2 (0.62) | CXCL8GLP1RGIPRGALR2GALR1 | |
| SCHEMBL29972944 | 0.89 | NPY1R (0.69) | GLP1RGCGRGIPRIL23R | |
| SCHEMBL30429251 | 0.88 | CALCA (0.62) | GLP1RGALR2GALR1 | |
| SCHEMBL30429667 | 0.88 | NMBR (0.60) | GLP1RGCGRGIPRNMBRGRPR | |
| SCHEMBL29972984 | 0.87 | NPY1R (0.65) | CXCL8GLP1RGCGRGIPR | |
| SCHEMBL31000909 | 0.86 | CXCL8 (0.64) | CXCL8GLP1RGCGRIL23R | |
| SCHEMBL29370578 | 0.86 | NPY1R (0.67) | GLP1RGCGRGIPRIL23R | |
| SCHEMBL30973903 | 0.86 | NPY1R (0.66) | GLP1RGCGRGIPRIL23R | |
| SCHEMBL31000914 | 0.86 | CXCL8 (0.62) | CXCL8GLP1RGCGRGIPRIL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4067370-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF PEPTIDES AND PEPTIDE RELATED COMPOUNDS | Yu, Chongxi (US) | 2022-10-05 | — | — | EP | disclosed |